Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 4/2015

01.12.2015 | Original Article

An exploratory analysis between dynamic change of metabolic syndrome and type 2 diabetes in a Chinese cohort

verfasst von: Hui Zhou, Chen Yang, Zhi-rong Guo, Xiao-Shu Hu, Yong Xu, Zhen-Yuan Zhou, PMMJS Study Group

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to analyze the impact of dynamic changes of the metabolic syndrome (MS) on the development of type 2 diabetes (T2DM). Subjects (3461) were recruited from a cohort study of Prevention of Multiple Metabolic disorders and MS in Jiangsu of China (PMMJS) with a follow-up of 3.8 years. The associations between the relative risk (RR) of T2DM and the dynamic changes (difference, the value at first follow-up subtract the value at baseline) of MS component numbers and each MS component were analyzed by using Cox regression model. The total incidence standardized rate of T2DM was 4.67 %. The incidence standardized rates of T2DM in the group of baseline MS−/first follow-up MS−, baseline MS+/first follow-up MS−, baseline MS−/first follow-up MS+, and baseline MS+/first follow-up MS+ were 2.16, 2.88, 9.56, and 10.75 % separately. MS subject numbers in four groups was significantly associated with risk of T2DM (aRR, 1.85; 95%CI, 1.62–2.09). Individuals with highest quartile of difference of MS component number (DMSCN) were approximately 3.92 times to develop T2DM than individuals with lowest quartile of DMSCN. After adjustment for the confounding factors, difference of systolic blood pressure (SBP), waist circumference (WC), high-density lipoprotein cholesterol (HDL-C), triglyceride (TG), and fasting plasma glucose (FPG) showed significant associations with the incidence of T2DM. The dynamic changes of MS component numbers and four groups on the basis of baseline and first follow-up MS and/or non-MS had the prediction ability of T2DM. In Chinese, the dynamic change of MS was a useful prediction factor for T2DM.
Literatur
1.
3.
Zurück zum Zitat Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care. 2003;26:3153–9.CrossRefPubMed Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care. 2003;26:3153–9.CrossRefPubMed
4.
Zurück zum Zitat The Exper Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160–7.CrossRef The Exper Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160–7.CrossRef
5.
Zurück zum Zitat Ford ES. Risks for all-causemortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28:1769–78.CrossRefPubMed Ford ES. Risks for all-causemortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005;28:1769–78.CrossRefPubMed
6.
Zurück zum Zitat Earl SF, Chaoyang L, Naveed S. Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care. 2008;31:1898–904.CrossRef Earl SF, Chaoyang L, Naveed S. Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care. 2008;31:1898–904.CrossRef
7.
Zurück zum Zitat Liu SJ, Guo ZR. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up. Diabetes Res Clin Pract. 2008;81:117–23.CrossRefPubMed Liu SJ, Guo ZR. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up. Diabetes Res Clin Pract. 2008;81:117–23.CrossRefPubMed
8.
Zurück zum Zitat Zhou H, Guo ZR. Evidence on the applicability of the ATPIII, IDF and CDS metabolic syndrome diagnostic criteria to identify CVD andT2DM in the Chinese population from a 6.3-year cohort study in mid-eastern China. Diabetes Res Clin Pract. 2010;90:319–25.CrossRefPubMed Zhou H, Guo ZR. Evidence on the applicability of the ATPIII, IDF and CDS metabolic syndrome diagnostic criteria to identify CVD andT2DM in the Chinese population from a 6.3-year cohort study in mid-eastern China. Diabetes Res Clin Pract. 2010;90:319–25.CrossRefPubMed
9.
Zurück zum Zitat Stinshoff K, Weisshaar D, Stachler F, et al. Relation between concentration of free glycerol and triglycerides in human sera. Clin Chem. 1977;23:1029–32.PubMed Stinshoff K, Weisshaar D, Stachler F, et al. Relation between concentration of free glycerol and triglycerides in human sera. Clin Chem. 1977;23:1029–32.PubMed
10.
Zurück zum Zitat Sugiuchi H, Uji Y, Okabe H, et al. Direct measurement of high density lipoprotein cholesterol in serum with polyethylene glycol modified enzymes and sulfated-cyclodextrin. Clin Chem. 1995;41:717–23.PubMed Sugiuchi H, Uji Y, Okabe H, et al. Direct measurement of high density lipoprotein cholesterol in serum with polyethylene glycol modified enzymes and sulfated-cyclodextrin. Clin Chem. 1995;41:717–23.PubMed
11.
Zurück zum Zitat Rifai N, Iannotti E, DeAnagelis K, et al. Analytical and clinical performance of a homogenous enzymatic LDL-cholesterol assay compared with the ultracentrifugation-dextran sulfate–Mg2+ method. Clin Chem. 1998;44:1242–50.PubMed Rifai N, Iannotti E, DeAnagelis K, et al. Analytical and clinical performance of a homogenous enzymatic LDL-cholesterol assay compared with the ultracentrifugation-dextran sulfate–Mg2+ method. Clin Chem. 1998;44:1242–50.PubMed
12.
Zurück zum Zitat Scott MG, James IC, Stephen RD, Karen AD, Robert HEL, Barry AF, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735–52.CrossRef Scott MG, James IC, Stephen RD, Karen AD, Robert HEL, Barry AF, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart Lung, and Blood Institute scientific statement. Circulation. 2005;112:2735–52.CrossRef
13.
Zurück zum Zitat Hu XS, Guo ZR, Zhou H, Shi ZM, Wu M, Zhang J, et al. Prevalence of metabolic syndrome in Jiangsu Province. Chin J Epidemiol. 2006;27(9):571–6. Hu XS, Guo ZR, Zhou H, Shi ZM, Wu M, Zhang J, et al. Prevalence of metabolic syndrome in Jiangsu Province. Chin J Epidemiol. 2006;27(9):571–6.
14.
Zurück zum Zitat National Bureau of Statistics of the People’s Republic of China, Communiqué on Major Figures of the 2000 Population Census (No. 1), 2002. National Bureau of Statistics of the People’s Republic of China, Communiqué on Major Figures of the 2000 Population Census (No. 1), 2002.
15.
Zurück zum Zitat Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289–304.CrossRefPubMed Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289–304.CrossRefPubMed
16.
Zurück zum Zitat Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino Sr RB, Wilson PW. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care. 2007;30:1219–25.CrossRefPubMed Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino Sr RB, Wilson PW. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care. 2007;30:1219–25.CrossRefPubMed
17.
Zurück zum Zitat Cheung BM, Wat NM, Man YB, Tam S, Thomas GN, Leung GM, et al. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care. 2007;30:1430–6.CrossRefPubMed Cheung BM, Wat NM, Man YB, Tam S, Thomas GN, Leung GM, et al. Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care. 2007;30:1430–6.CrossRefPubMed
18.
Zurück zum Zitat Cameron AJ, Zimmet PZ, Soderberg S, Alberti KG, Sicree R, Tuomilehto J, et al. The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius. Diabet Med. 2007;24:1460–9.CrossRefPubMed Cameron AJ, Zimmet PZ, Soderberg S, Alberti KG, Sicree R, Tuomilehto J, et al. The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius. Diabet Med. 2007;24:1460–9.CrossRefPubMed
19.
Zurück zum Zitat Cameron AJ, Magliano DJ, Zimmet PZ, Welborn TA, Colagiuri S, Tonkin AM, et al. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. J Intern Med. 2008;264:177–86.CrossRefPubMed Cameron AJ, Magliano DJ, Zimmet PZ, Welborn TA, Colagiuri S, Tonkin AM, et al. The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. J Intern Med. 2008;264:177–86.CrossRefPubMed
20.
Zurück zum Zitat Hadaegh F, Ghasemi A, Padyab M, Tohidi M, Azizi F. The metabolic syndrome and incident diabetes: assessment of alternative definitions of the metabolic syndrome in an Iranian urban population. Diabetes Res Clin Pract. 2008;80:328–34.CrossRefPubMed Hadaegh F, Ghasemi A, Padyab M, Tohidi M, Azizi F. The metabolic syndrome and incident diabetes: assessment of alternative definitions of the metabolic syndrome in an Iranian urban population. Diabetes Res Clin Pract. 2008;80:328–34.CrossRefPubMed
21.
Zurück zum Zitat Hanley AJ, Karter AJ, Williams K, Festa A, D'Agostino Jr RB, Wagenknecht LE, et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation. 2005;112:3713–21.CrossRefPubMed Hanley AJ, Karter AJ, Williams K, Festa A, D'Agostino Jr RB, Wagenknecht LE, et al. Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation. 2005;112:3713–21.CrossRefPubMed
22.
Zurück zum Zitat Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066–72.CrossRefPubMed Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066–72.CrossRefPubMed
23.
Zurück zum Zitat Sattar N, Gaw A, Scherbakova O, Ford I, O’Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108:414–9.CrossRefPubMed Sattar N, Gaw A, Scherbakova O, Ford I, O’Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation. 2003;108:414–9.CrossRefPubMed
24.
Zurück zum Zitat Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289–304.CrossRefPubMed Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289–304.CrossRefPubMed
25.
Zurück zum Zitat Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care. 2003;26:3153–9.CrossRefPubMed Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care. 2003;26:3153–9.CrossRefPubMed
26.
Zurück zum Zitat Ferrannini E, Gastaldelli A. Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab. 2005;90:493–500.CrossRefPubMed Ferrannini E, Gastaldelli A. Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab. 2005;90:493–500.CrossRefPubMed
27.
Zurück zum Zitat Nasila SJ, Tyler J, Longo-Mbenza B, Lasi On'Kin JB, Gombet T, Erasmus RT. Assessing clustering of metabolic syndrome components available at primary care for Bantu Africans using factor analysis in the general population. BMC Res Notes. 2013;6:228. doi:10.1186/1756-0500-6-228.CrossRef Nasila SJ, Tyler J, Longo-Mbenza B, Lasi On'Kin JB, Gombet T, Erasmus RT. Assessing clustering of metabolic syndrome components available at primary care for Bantu Africans using factor analysis in the general population. BMC Res Notes. 2013;6:228. doi:10.​1186/​1756-0500-6-228.CrossRef
28.
Zurück zum Zitat Wassink AMJ, Van Der Graaf Y, Soedamah-Muthu S, Spiering W, Visseran FLJ. Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease. Diabetes Vasc Dis Res. 2008;5:114–22.CrossRef Wassink AMJ, Van Der Graaf Y, Soedamah-Muthu S, Spiering W, Visseran FLJ. Metabolic syndrome and incidence of type 2 diabetes in patients with manifest vascular disease. Diabetes Vasc Dis Res. 2008;5:114–22.CrossRef
29.
Zurück zum Zitat Sheu WH, Chuang SY, Lee WJ, Tsai ST, Chou P, Chen CH. Predictors of incident diabetes, metabolic syndrome in middle-aged adults: a 10-year follow-up study from Kinmen, Taiwan. Diabetes Res Clin Pract. 2006;74:162–8.CrossRefPubMed Sheu WH, Chuang SY, Lee WJ, Tsai ST, Chou P, Chen CH. Predictors of incident diabetes, metabolic syndrome in middle-aged adults: a 10-year follow-up study from Kinmen, Taiwan. Diabetes Res Clin Pract. 2006;74:162–8.CrossRefPubMed
Metadaten
Titel
An exploratory analysis between dynamic change of metabolic syndrome and type 2 diabetes in a Chinese cohort
verfasst von
Hui Zhou
Chen Yang
Zhi-rong Guo
Xiao-Shu Hu
Yong Xu
Zhen-Yuan Zhou
PMMJS Study Group
Publikationsdatum
01.12.2015
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 4/2015
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-015-0332-1

Weitere Artikel der Ausgabe 4/2015

International Journal of Diabetes in Developing Countries 4/2015 Zur Ausgabe